Share trading in Genmab, the Danish biotech company, experienced a flat first day on Frankfurt's Neuer Markt and even its home market the Copenhagen Stock Exchange.
Genmab, which on Wednesday launched a dual listing in Denmark and Germany, saw its shares trading down on both markets.